A need for effective adjuvants.
Bunce
Campbell J
CJ
Morse
Michael A
MA
D000276:Adjuvants, Immunologic / Q000009:adverse effects / Q000494:pharmacology*; D000535:Aluminum / Q000009:adverse effects / Q000494:pharmacology*; D000818:Animals; D001428:Bacterial Vaccines / Q000008:administration & dosage; D016207:Cytokines / Q000008:administration & dosage; D016503:Drug Delivery Systems / Q000379:methods* / Q000639:trends; D006801:Humans; D011994:Recombinant Proteins / Q000276:immunology; D014612:Vaccines / Q000008:administration & dosage / Q000276:immunology*; D019444:Vaccines, DNA / Q000008:administration & dosage
D000276:Adjuvants, Immunologic; D001428:Bacterial Vaccines; D016207:Cytokines; D011994:Recombinant Proteins; D014612:Vaccines; D019444:Vaccines, DNA; D000535:Aluminum